Table 1 Patient characteristics of the baseline and intervention patient population
2011 (Baseline) | 2012 (Intervention) | Odds ratio (95 % CI) | P value | |
|---|---|---|---|---|
Total n | 128 | 124 | ||
Age | 63.4 | 62.8 | 0.29 | |
Male | 74 (57.8 %) | 74 (59.7 %) | 1.1 (0.7–1.7) | 0.76 |
Hospital 1 (vs. Hospital 2) | 69 (53.9 %) | 64 (51.6 %) | 0.9 (0.6–1.5) | 0.71 |
MSSA (vs. MRSA) | 97 (75.8 %) | 100 (80.6 %) | 1.3 (0.7–2.4) | 0.35 |
Palliative | 5 (3.9 %) | 8 (6.5 %) | 1.7 (0.5–5.3) | 0.36 |
ID Involvement | ||||
Overall | 93/128 (72.7 %) | 103/124 (83.1 %) | 1.9 (1.1–3.3) | 0.047 |
Hospital 1 | 61/69 (88.4 %) | 56/64 (87.5 %) | 0.9 (0.3–2.5) | 0.87 |
Hospital 2 | 32/59 (54.2 %) | 47/60 (78.3 %) | 3.0 (1.4–10.0) | 0.005 |
Time to ID Involvement | ||||
Days, median (IQR) | 2 (1–3) | 1 (1–2) | n/a | 0.001 |
Mortality | ||||
Overall | 37/128 (28.9 %) | 35/124 (28.2 %) | 0.97 (0.6–1.7) | 0.91 |
Palliative cases excluded | 34/123 (27.6 %) | 31/116 (26.7 %) | 0.96 (0.5–1.7) | 0.87 |
Relapse | 0 | 0 | n/a | n/a |
Readmission | 1/128 (0.01 %) | 1/124 (0.01 %) | 1.0 (0.6–16.7) | 0.98 |